VACCINATION

Pakistan’s current extensively drug resistant (XDR) outbreak of typhoid is the first-ever resistant to ceftriazone.

The European Commission described the decision as a major step forward in saving lives in Africa and beyond.

The tetravalent dengue vaccine showed 80.2% efficacy in healthy children and adolescents in endemic regions.

While larger trials will be needed to better assess the vaccine's efficacy, the results are seen as very promising in the future global response against TB

Major potential breakthrough for haemorrhagic Lassa fever, which infects up to 300,000 people in endemic West African countries annually.

The European Medicines Agency has recommended granting a conditional marketing authorisation in the EU for the rVSV-ZEBOV-GP vaccine.

As measles continues to circulate in the Region, a stronger response by the international community is needed, the WHO said.

This new vaccine technology could revolutionise the way vaccines are designed, produced and stored.

The move is in keeping with recent recommendations from WHO’s Strategic Advisory Group of Experts on Immunization (SAGE).

The findings challenge current WHO guidelines which advocate a single vaccine dose for life-long protective immunity against yellow fever.

At the end of 2018, four European countries lost their measles elimination status, while rubella cases are also on the rise.

These 2019 recommendations were formulated based on evidence and expert opinion following four systematic literature reviews.

The ongoing circulation of measles in Europe continues to be internally classified within the World Health Organization as a Grade 2 emergency.

The most common HPV-attributable cancers reported during the study period were cervical and oropharyngeal.